ArticleFrontiers in medicine2025
Clinical and laboratory characteristics of hidradenitis suppurativa in a Chinese cohort: a retrospective analysis of 197 cases.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decreased HDL-C in hidradenitis suppurativa: association with systemic inflammatory phenotype and implications for risk stratification.Lipids in health and disease · 2026Article
- Laboratory Parameters Can Serve as Objective Auxiliary Tools for Assessing Disease Severity in Hidradenitis Suppurativa: A 5-Year Period Single-Center Retrospective Study.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical and laboratory characteristics of hidradenitis suppurativa (HS), particularly indicators related to disease severity, remain inadequately explored in Asian populations. Objectives: To characterize the clinical and laboratory features of HS in Chinese patients and to identify risk factors for disease severity. Methods: We retrospectively analyzed 197 patients with HS in China. Demographic, clinical, and laboratory data were collected. Disease severity was graded using the Hurley staging system. Comprehensive statistical analyses were conducted. Results: Among 197 patients, 87.8% were male (male-to-female ratio 7.2:1). Females had a shorter diagnostic delay than males ( Conclusion: Chinese patients with HS exhibited a pronounced male predominance and relatively mild metabolic abnormalities. Neutrophil-related indices and TP, especially when TP was interpreted together with albumin, were associated with progression to Hurley stage III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.